Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Oral Pathology & Medicine

• Publication date

  2008-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1600-0714.2008.00689.xPMID 18710422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India

  2009cited by this paper
• Apoptosis-associated proteins in oral hairy leukoplakia.

  2008cited by this paper
• Cell proliferation and apoptosis culminate in early stages of oral oncogenesis.

  2006cited by this paper
• Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma.

  2006cited by this paper
• Expression of Bcl‐xL, Bax, and p53 in Primary Tumors and Lymph Node Metastases in Oral Squamous Cell Carcinoma

  2006cited by this paper
• Targeting the Bcl-2 family in cancer therapy.

  2006cited by this paper
• Loss of BCL-2 in the progression of oral cancer is not attributable to mutations

  2005cited by this paper
• Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

  2003cited by this paper
• Expression of bcl-2 in oral squamous cell carcinoma: an immunohistochemical study of 90 cases with clinico-pathological correlations.

  2003cited by this paper
• JNK and ERK signaling pathways in multistage mouse carcinogenesis: studies in the inhibition of signaling cascades as a means to understand their in vivo biological role.

  2002cited by this paper
• The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma

  2001cited by this paper
• Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.

  2001cited by this paper
• Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis.

  2001cited by this paper
• Differing expression of bax and bcl-3 may influence the different cure rates in mouth and orophayrngeal cancer

  2000cited by this paper
• Basaloid Squamous Cell Carcinoma of the Head and Neck

  2000cited by this paper
• Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

  2000cited by this paper
• Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner

  1999cited by this paper
• Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A.

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Apoptosis-associated proteins and the development of oral squamous cell carcinoma.

  1999cited by this paper
• Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma.

  1999cited by this paper
• The prognostic value of spontaneous apoptosis, Bax, Bcl‐2, and p53 in oral squamous cell carcinoma of the tongue

  1999cited by this paper
• BCL-2 family members and the mitochondria in apoptosis.

  1999cited by this paper
• Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma.

  1998cited by this paper
• Apoptosis is inversely related to bcl‐2 but not to bax expression in salivary gland tumours

  1998cited by this paper
• bax, but notbcl-2, influences the prognosis of human pancreatic cancer

  1998cited by this paper
• Biological markers as indicators of pathological response to primary chemotherapy in oral‐cavity cancers

  1998cited by this paper
• Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma.

  1998cited by this paper
• Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity.

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• Prognostic Significance of BCL-2 Expression in Localized Squamous Cell Carcinoma of the Head and Neck

  1997cited by this paper
• Conversion of Bcl-2 to a Bax-like death effector by caspases.

  1997cited by this paper
• Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer.

  1997cited by this paper
• Differential Expression of Apoptosis-Associated Genes bax and bcl-2 in Ovarian Cancer.

  1997cited by this paper
• Expression of bcl‐2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis

  1997cited by this paper
• Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity.

  1996cited by this paper
• Differential expression of the bcl-2 oncogene in human basal cell carcinoma.

  1996cited by this paper
• Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy.

  1996cited by this paper
• Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions.

  1996cited by this paper
• Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosis

  1995cited by this paper
• Regulators of cell death.

  1995cited by this paper
• Bcl-2 overexpression and smoking history in head and neck cancer.

  1995cited by this paper
• Bcl-2: prevention of apoptosis as a mechanism of drug resistance.

  1995cited by this paper
• Genomic components of carcinogenesis.

  1993cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• GTP hydrolysis is required for vesicle fusion during nuclear envelope assembly in vitro

  1992cited by this paper

• Effect of Topical Application of Resveratrol Loaded Chitosan Nanoparticles on Chemically Induced Epithelial Dysplasia in Hamster Pouch.

  2025cites this paper
• Exploring anticancer potential of betanin in DMBA-induced oral squamous cell carcinoma: an in silico and experimental study

  2025cites this paper
• In vitro assessment of Moringa Oleifera leaf extract’s protective impact on fibroblast cell line (WI-38) exposed to electronic cigarette liquid

  2025cites this paper
• Analysis of Co-expression of HSP 70 and BCL 2 in Oral Precancer and Cancer Patients Using Immunohistochemistry

  2024cites this paper
• A Combination of Curcumin and Lactobacillus rhamnosus GG Inhibits Viability and Induces Apoptosis in SCC-9 Human Oral Squamous Cell Carcinoma Cells

  2024cites this paper
• Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma

  2023cites this paper
• Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts

  2023cites this paper
• Connexin 43, Bcl-2, Bax, Ki67, and E-cadherin patterns in oral squamous cell carcinoma and its relationship with GJA1 rs12197797 C/G

  2022cites this paper
• Adverse effects of SYP-3343 on zebrafish development via ROS-mediated mitochondrial dysfunction.

  2022cites this paper
• Immunohistochemical Characterization of Bcl-2 in Oral Potentially Malignant Disorders.

  2021cites this paper
• Prognostic Implications of EGFR, p53, p16, Cyclin D1, and Bcl‐2 in Head and Neck Squamous Cell Carcinoma (HNSCC)

  2020cites this paper
• The Microenvironment of Tongue Cancer.

  2020cites this paper
• Recurrent and metastatic extragastrointestinal stromal tumors of the mesentery with C-KIT and PDGFRA mutations: a case report

  2020cites this paper
• Evaluation of lymphocyte apoptosis in patients with oral cancer

  2020cites this paper
• Unsupervised Clustering of Immunohistochemical Markers to Define High-Risk Endometrial Cancer

  2019cites this paper
• Oral Cancer

  2019cites this paper
• Cell cycle markers and apoptotic proteins in oral tongue squamous cell carcinoma in young and elderly patients.

  2019cites this paper
• Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance

  2018cites this paper
• To Evaluate the Immunohistochemical Expression of Bcl2 and Bax in Oral Squamous Cell Carcinoma

  2018cites this paper
• Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells.

  2018cites this paper
• Prognostic significance of p 16 , p 53 , Bcl-2 , and Bax in oral and oropharyngeal squamous cell carcinoma

  2017influential citation
• Squamous Cell Carcinoma: Biomarkers and Potential Therapeutic Targets

  2017cites this paper
• Possible Role of Bcl-2 Expression in Metastatic and Non Metastatic Oral Squamous Cell Carcinoma.

  2017cites this paper
• Prädiktive Biomarker für die Entwicklung von high grade acute organ toxicity im Rahmen der Radiochemotherapie bei Patienten mit Kopf-Hals-Tumoren

  2017cites this paper
• CROMOLYN INHIBITS 7, 12-DIMETHYLBENZ (A) ANTHRACENE INDUCED ORAL CANCER THROUGH APOPTOTIC INDUCTION AND SUPPRESSION OF CELL PROLIFERATION

  2016cites this paper
• Anticancer effect of thalidomide in vitro on human osteosarcoma cells.

  2016cites this paper
• Clinicopathological correlation of Bcl-2 oncoprotein expression in oral precancer and cancer.

  2016cites this paper
• An overview of oral carcinogenesis

  2016cites this paper
• Evaluation of Clinical, Demographic, Pathological, and Molecular Factors with Survival Rate of Patients with Oral Squamous cell Carcinoma in Yazd city During 1998–2008

  2015cites this paper
• ResearchThe conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC 7901 human gastric cancer cells

  2015cites this paper
• Oncoapoptotic Markers in Oral Cancer: Prognostics and Therapeutic Perspective

  2014cites this paper
• Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.

  2014cites this paper
• Prognostic significance of p16, p53, Bcl-2, and Bax in oral and oropharyngeal squamous cell carcinoma

  2014influential citation
• Association between SNPs in P53 Binding Regions and Risk of Esophageal Squamous Cell Carcinoma

  2014cites this paper
• Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma

  2013cites this paper
• Apigenin prevents deregulation in the expression pattern of cell-proliferative, apoptotic, inflammatory and angiogenic markers during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.

  2013cites this paper
• Assessment of Bax and Bcl-2 Immunoexpression in Patients with Oral Lichen Planus and Oral Squamous Cell Carcinoma

  2013cites this paper
• Correlation of P53 and granzyme B expression in oral squamous cell carcinoma with clinicopathologic findings.

  2013cites this paper
• Anti-Tumor Effect of Rutin on Human Neuroblastoma Cell Lines through Inducing G2/M Cell Cycle Arrest and Promoting Apoptosis

  2013cites this paper
• Clinicopathologic evaluation of Pro- and antiapoptotic marker expression in oral squamous cell carcinoma

  2013cites this paper
• Functional Biomarkers of Oral Cancer

  2012cites this paper
• Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis

  2012cites this paper
• Estrogen receptor-regulated microRNAs contribute to the BCL2/BAX imbalance in endometrial adenocarcinoma and precancerous lesions.

  2012cites this paper
• Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma

  2012cites this paper
• Anti-cancer properties of glucosamine-hydrochloride in YD-8 human oral cancer cells: Induction of the caspase-dependent apoptosis and down-regulation of HIF-1α.

  2012cites this paper
• Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma.

  2011cites this paper
• The clinicopathological significance of the expression of Granzyme B in oral squamous cell carcinoma.

  2010cites this paper
• Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review

  2010cites this paper
• Apoptotic factors (Bcl-2 and Bax) and diabetic retinopathy in type 2 diabetes

  2010cites this paper
• Distinctive clinical and microscopic features of squamous cell carcinoma of oral cavity and lip.

  2010cites this paper
• World Journal of Surgical Oncology Open Access Research the Conformation Change of Bcl-2 Is Involved in Arsenic Trioxide-induced Apoptosis and Inhibition of Proliferation in Sgc7901 Human Gastric Cancer Cells

  year unknowncites this paper